|
||||||||
 |
 Media partners and press |
|
|||||
 |
 |
|||||
| Drug Discovery Today. |
Genetic Engineering & Biotechnology News. | |||||
| Since its launch in 1996, Drug Discovery Today has been at the cutting edge of the science underpinning drug discovery and development. We deliver highly current reviews to our readers, not only addressing the rapid scientific developments in drug discovery associated technologies, but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. |
Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publishing brand around the globe since its launch in 1981. What began as a print publication has now expanded to leverage online media including web exclusive news and features, webinars, videos, podcasts, and newsletters. GEN's therapeutic and technology coverage includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers,as well as diagnostics,and to bioprocessing and commercialisation. |
|||||
 |
 |
|||||
| Frost & Sullivan. |
Drug Discovery & Development | |||||
| The Healthcare & Life Sciences IT Growth Par tnership Ser vices program combines our range of services, global perspective, and comprehensive market coverage to provide the tools that empower our clients to achieve their growth objectives. Through this program clients receive a continuous flow of market, technical, and econometric information , along with interactive applications (our TEAM methodology) focused specifically on growth. A sample list of our market coverage includes Medical Care Providers, Managed Care Ser vices, Consumer-based Healthcare, Clinical Solutions, Business Solutions, and Healthcare Outsourcing. |
Drug Discovery & Development magazine delivers insight into the full landscape of technologies, tools, and business/regulatory strategies that help scientists and executives accelerate the pace and productivity of drug research and development. Articles are concise, with practical intent: to present information for day-to-day technical and business decision-making. | |||||
 |
 |
|||||
| Future Medicinal Chemistry | Pharma Voice |
|||||
| Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology. |
PharmaVOICE magazine, reaching more than 20,500 BPA-qualifiedlife-sciences executives, is the forum that allows business leaders toengage in a candid dialogue on the challenges and trends impacting theindustry. PharmaVOICE, and its supporting VIEW publications, providereaders with insightful and thought-provoking commentary in amultiple-perspective format through forums, topics, and articles coveringa range of issues from molecule through market. PharmaVOICE subscribersare also kept abreast of the latest trends and information throughadditional media resources, including WebLinx Interactive WebSeminars,Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally,PharmaVOICEMarketplace.com provides a comprehensive directory of products,services, and solutions for the life-sciences industry.m. | |||||
 |
 |
|||||
| Providing a valuable resource for researchers and business leaders, Bioinformatics.net is a web portal dedicated to the field of using statistics and computer science in Molecular Biology to help understand biological processes. Updated on a daily basis, the unique mix of exclusive presentations, specialist supplier listings, events, news, scientific posters and new products makes this a one-stop-shop for essential information. | Celebrating it’s 10th year DDW has firmly established itself as a highly respected and the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics.
DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms. |
|||||
 |
||||||
| Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and the wider clinical community. | ||||||
|
|
|
